课题基金 / 基金详情

SEROTONERGIC ABNORMALITIES IN SEASONAL AFFECTIVE DISORDER AND LIGHT THERAPY

SEROTONERGIC ABNORMALITIES IN SEASONAL AFFECTIVE DISORDER AND LIGHT THERAPY
季节性情感障碍和光疗中的血清素异常
批准号:
6111189
负责人:
N E ROSENTHAL
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

N E ROSENTHAL的其他基金

相似基金

相关文献

中文摘要
翻译
我们先前的研究表明,5-羟色胺能机制参与了 季节性情感障碍(SAD)的病理生理学研究进展 光疗的治疗作用。给予异常兴奋--欣快感 5-羟色胺激动剂间氯苯基哌嗪(m-CPP)对血管内皮细胞的反应 患有SAD的患者,我们测试了SAD患者也会 对这种药物表现出异常的大脑代谢反应,由 正电子发射断层扫描(PET)。之前确认的结果 以下患者与对照组的激活-欣快感的比较 M-CPP管理。我们发现在大脑中没有全球差异 患者的新陈代谢与对照组在基线或 在毒品挑战之后。局灶性脑出血的可能性 患者的代谢差异有待未来的数据分析。一秒钟内 PET扫描研究我们测试了以下假设:(1)一小时的光疗 会倾向于使边缘和边缘附近的血流水平正常化 大脑区域,对对照组没有影响,(2) 暴露1小时后对光疗法的抗抑郁反应 会与服用抗抑郁药一周和两周后的反应相关 光疗法。结果有待未来的数据分析。 研究光疗法的抗抑郁作用是否可能 通过5-羟色胺或儿茶酚胺能机制发生, 接受光疗缓解的患者经历了独立的脑耗尽 5羟色胺和儿茶酚胺。5-羟色胺和儿茶酚胺耗尽 不含色氨酸的氨基酸饮料(外加氨基酸胶囊)和 酪氨酸羟化酶抑制剂α-甲基-对酪氨酸。两者都有 耗尽程序,与假耗尽相比,同样逆转了 光疗的抗抑郁作用。在正在进行的研究中 淋巴母细胞系,我们试图发现异常 SAD患者5-羟色胺能功能相关基因的多态性 病人。我们发现5-羟色胺的短等位基因 转运体连锁多态(5-HTTLPR)也与SAD相关 随着季节性程度的提高(与季节性相关的行为 SAD患者的情绪、能量、食欲等方面的变化。
英文摘要
Our prior research suggests that serotonergic mechanisms are involved in the pathophysiology of seasonal affective disorder (SAD) and the therapeutic action of light therapy. Given abnormal activation-euphoric responses to the serotonin agonist m-chlorophenylpiperazine (m-CPP) in patients with SAD, we tested the hypothesis that SAD patients would also exhibit abnormal cerebral metabolic responses to this drug, as measured by positron emission tomography (PET) scanning. Results confirmed previous findings of activation-euphoria in patients compared to controls following m-CPP administration. We found no global differences in cerebral metabolism in patients as compared to controls either at baseline or following the drug challenge. The possibility of regional cerebral metabolic differences in patients await future data analysis. In a second PET scan study we tested the hypotheses that (1) one hour of light therapy would tend to normalize the level of blood flow in limbic and paralimbic regions of the brain and exert no effect on controls and (2) the antidepressant response to light therapy following one hour of exposure will correlate with the antidepressant response after one and two weeks of light therapy. Results await future data analysis. To investigate whether the antidepressant effects of light therapy might occur through either serotonergic or catecholaminergic mechanisms, patients remitted on light therapy underwent independent depletions of serotonin and catecholamines. Serotonin and catecholamines were depleted with a tryptophan-free amino acid beverage (plus amino acid capsules) and the tyrosine hydroxylase inhibitor alpha-methyl-para-tyrosine. Both depletion procedures, compared to sham depletion, equally reversed the antidepressant effects of light therapy. In ongoing studies of lymphoblastoid cell lines, we have attempted to find abnormal polymorphisms in genes related to serotonergic functioning in SAD patients. We have found that the short allele of the 5-HT transporter-linked polymorphism (5-HTTLPR) is associated with SAD, as well as with greater levels of seasonality (seasonally-related behavioral changes such as mood, energy, appetite) in patients with SAD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTIDEPRESSANT EFFECTS OF LIGHT IN SEASONAL AFFECTIVE DISORDER AND NORMAL CONTROL
NEUROBIOLOGY OF SEASONAL AFFECTIVE DISORDER
CLINICAL ASPECTS OF WINTER SEASONAL AFFECTIVE DISORDER
NEUROBIOLOGY OF SEASONAL AFFECTIVE DISORDER AND LIGHT THERAPY
海外基金